Victoria Song

Senior Reviewer, Wearable Tech

Victoria Song is a senior reviewer for The Verge and author of Optimizer, a weekly newsletter that cuts through the hype to uncover what tech actually makes your life better. She specializes in emerging technologies in wearables, health and fitness, and XR. Before coming to The Verge, she’s been reporting on consumer tech for Gizmodo and PC Magazine. In another life, she worked on the business and breaking news desk for The Yomiuri Shimbun. When not nerding out, she can be found swearing while running or on the couch binging the latest K-dramas. You can reach her on Signal: @vicmsong.14

Amazon’s always-listening Bee wearable can now help you buy stuff

Victoria SongOct 15

My AI doppelganger tells me what to eat

In return for feeding a ‘digital twin’ my metabolic data, it predicts how I’ll react to certain foods — and one day, maybe medicines.

Victoria SongOct 14

Verge Score

I don’t miss the camera on the Ray-Ban Meta Audio glasses

It’s harder to be a perv in these audio-only glasses, but removing the ick does make them less ‘useful.’

Victoria SongOct 13

The Fitbit Edge is for folks who don’t want to go totally screenless

Victoria SongOct 12

Victoria SongOct 8

The Trump administration seems like its leaning toward allowing unapproved peptides.

So says The Washington Post. I’ve been writing about gray-market peptides in Optimizer, but this is a follow-up to July’s FDA hearings about whether compounding pharmacies should be allowed to sell unapproved peptides. It’s unclear which ones, and the timing could change, but the Post says this might give the administration a “political upside.”

Trump administration paving way for temporary sale of some unapproved peptides

[The Washington Post]